ATE402942T1 - Verfahren zur reduzierung des eisengehalts bei risedronat natrium - Google Patents

Verfahren zur reduzierung des eisengehalts bei risedronat natrium

Info

Publication number
ATE402942T1
ATE402942T1 AT04702936T AT04702936T ATE402942T1 AT E402942 T1 ATE402942 T1 AT E402942T1 AT 04702936 T AT04702936 T AT 04702936T AT 04702936 T AT04702936 T AT 04702936T AT E402942 T1 ATE402942 T1 AT E402942T1
Authority
AT
Austria
Prior art keywords
risedronate sodium
iron content
reducing iron
iron
sodium
Prior art date
Application number
AT04702936T
Other languages
English (en)
Inventor
Revital Lifshitz-Liron
Rami Lidor-Hadas
Nissm Sasson
Igor Lifshitz
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharma filed Critical Teva Pharma
Application granted granted Critical
Publication of ATE402942T1 publication Critical patent/ATE402942T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576—Six-membered rings
    • C07F9/59—Hydrogenated pyridine rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
AT04702936T 2003-01-17 2004-01-16 Verfahren zur reduzierung des eisengehalts bei risedronat natrium ATE402942T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44106203P 2003-01-17 2003-01-17
US44513903P 2003-02-05 2003-02-05

Publications (1)

Publication Number Publication Date
ATE402942T1 true ATE402942T1 (de) 2008-08-15

Family

ID=32776044

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04702936T ATE402942T1 (de) 2003-01-17 2004-01-16 Verfahren zur reduzierung des eisengehalts bei risedronat natrium

Country Status (11)

Country Link
US (1) US7358360B2 (de)
EP (1) EP1583768B1 (de)
JP (2) JP3869456B2 (de)
AT (1) ATE402942T1 (de)
CA (1) CA2513543A1 (de)
DE (1) DE602004015407D1 (de)
ES (1) ES2311142T3 (de)
IL (1) IL169569A (de)
PL (1) PL377878A1 (de)
PT (1) PT1583768E (de)
WO (1) WO2004065397A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0300227A2 (hu) * 2003-01-28 2004-09-28 Richter Gedeon Vegyészeti Gyár Rt. Eljárás nagy tisztaságú 2-szubsztituált -1-(hidroxi-etilidén)-1,1-biszfoszfonsavak és sóik előállítására
US20080286359A1 (en) 2004-05-24 2008-11-20 Richard John Dansereau Low Dosage Forms Of Risedronate Or Its Salts
US7645459B2 (en) 2004-05-24 2010-01-12 The Procter & Gamble Company Dosage forms of bisphosphonates
US20080287400A1 (en) 2004-05-24 2008-11-20 Richard John Dansereau Low Dosage Forms Of Risedronate Or Its Salts
US7645460B2 (en) 2004-05-24 2010-01-12 The Procter & Gamble Company Dosage forms of risedronate
WO2006129056A2 (en) * 2005-05-28 2006-12-07 Pliva Hrvatska D.O.O Process and novel salt
JP5354858B2 (ja) * 2006-05-09 2013-11-27 株式会社Ａｄｅｋａ スルホンアミド化合物の金属塩を含有するポリエステル樹脂組成物
WO2007132478A2 (en) 2006-05-11 2007-11-22 Ind-Swift Laboratories Limited Process for the preparation of pure risedronic acid or salts
WO2009050731A2 (en) * 2007-06-20 2009-04-23 Alkem Laboratories Ltd Novel process for preparing risedronic acid

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3623397A1 (de) * 1986-07-11 1988-01-14 Boehringer Mannheim Gmbh Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
SE9901272D0 (sv) * 1999-04-09 1999-04-09 Astra Ab New improved formulation
US6677320B2 (en) * 2000-01-20 2004-01-13 Hoffmann-La Roches Inc. Parenteral bisphosphonate composition with improved local tolerance
US6410520B2 (en) * 2000-02-01 2002-06-25 The Procter & Gamble Company Selective crystallization of 3-pyridyl-1-hydroxyethylidene-1, 1-bisphosphonic acid sodium as the hemipentahydrate or monohydrate
MXPA04010009A (es) * 2002-04-11 2005-07-01 Teva Pharma Polimorfos y pseudopolimorfos de sodio de risedronato novedosos.
US7645460B2 (en) * 2004-05-24 2010-01-12 The Procter & Gamble Company Dosage forms of risedronate

Also Published As

Publication number Publication date
PL377878A1 (pl) 2006-02-20
WO2004065397A1 (en) 2004-08-05
PT1583768E (pt) 2008-09-11
IL169569A (en) 2010-04-29
JP2007008956A (ja) 2007-01-18
EP1583768A1 (de) 2005-10-12
US7358360B2 (en) 2008-04-15
DE602004015407D1 (de) 2008-09-11
CA2513543A1 (en) 2004-08-05
JP3869456B2 (ja) 2007-01-17
JP2006515867A (ja) 2006-06-08
ES2311142T3 (es) 2009-02-01
EP1583768B1 (de) 2008-07-30
US20040192655A1 (en) 2004-09-30

Similar Documents

Publication Publication Date Title
MY164311A (en) Process to remove impurities from triacylglycerol oil
ATE458535T1 (de) Verfahren zur herstellung von konzentrierten tensidzusammensetzungen
ATE402942T1 (de) Verfahren zur reduzierung des eisengehalts bei risedronat natrium
MY141005A (en) Branched biodiesels
MY148921A (en) Enzymatic oil interesterification
AU2002359522A8 (en) Compositions and methods of selective nucleic acid isolation
ATE527218T1 (de) Verfahren zur hemmung der korrosion
MX2009003942A (es) Compuestos de quinolina.
MXPA01009299A (es) Aditivo inhibidor de corrosion no carcinogenico.
MX2007004884A (es) Generacion de plantas con contenido alterado de aceite.
DOP2007000029A (es) Composiciones antimicóticas de ramnolípidos y métodos relacionados con su uso
UA97346C2 (ru) Стабильная эмульсионная композиция
DE602006008770D1 (de) Verfahren zur hydrolyse von polyphosphorsäure in geformten artikeln
DE602005015872D1 (de) Zusammensetzung und verfahren zur medizinischen bilddarstellung von körperhöhlen
MX2007001463A (es) Composiciones de anti-espuma que contienen acidos grasos y de colofonia o derivados de los mismos.
ATE463468T1 (de) Verwendung von magnesiumphosphat zur wasserenthärtung
SG136026A1 (en) Oil extraction
MX2009006462A (es) Generacion de plantas con contenido de aceite, proteina o fibra alterado.
ATE486116T1 (de) Verfahren zur verschiebung von sauergasanteilen innerhalb eines erdgasnetzwerkes
DE602005025140D1 (de) Verfahren zur herstellung von alkylphosphinaten
ATE414049T1 (de) Schwindvermindernder zusatzstoff für zementzusammensetzungen
MXPA05013595A (es) Proceso para aumentar la extraccion de liquido de las telas.
MY153071A (en) Buble-containing solid ?-sulfo fatty acid alkyl ester salt and method for producing the same
ATE365759T1 (de) Verfahren zur isolierung von polyorganosiloxanen
TW200728268A (en) Processes for the preparations of optically active cyclopentenones and cyclopentenones prepared therefrom

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties